| Literature DB >> 34015418 |
Pol Escudé Martinez de Castilla1, Lingjun Tong2, Chenyuan Huang2, Alexandros Marios Sofias3, Giorgia Pastorin4, Xiaoyuan Chen5, Gert Storm6, Raymond M Schiffelers7, Jiong-Wei Wang8.
Abstract
During the past decades, extracellular vesicles (EVs) have emerged as an attractive drug delivery system. Here, we assess their pre-clinical applications, in the form of a systematic review. For each study published in the past decade, disease models, animal species, EV donor cell types, active pharmaceutical ingredients (APIs), EV surface modifications, API loading methods, EV size and charge, estimation of EV purity, presence of biodistribution studies and administration routes were quantitatively analyzed in a defined and reproducible way. We have interpreted the trends we observe over the past decade, to define the niches where to apply EVs for drug delivery in the future and to provide a basis for regulatory guidelines.Entities:
Keywords: Clinical trial; Drug delivery; Extracellular vesicles; Liposomes; Preclinical animal models; Systematic review
Mesh:
Year: 2021 PMID: 34015418 DOI: 10.1016/j.addr.2021.05.011
Source DB: PubMed Journal: Adv Drug Deliv Rev ISSN: 0169-409X Impact factor: 15.470